• About
    • Our Mission
    • Threat of AMR
    • Access and Appropriate Use Principles
    • Our Investors
  • Team
  • Investments
    • How We Invest
    • Our Portfolio
    • Get On Our Radar
  • News
  • Connect

Posts about In the News (5):

  • All
  • In the News
  • Press Releases
  • Media
August 10, 2023
In the News

Forbes: “The Critical Fix We Need to Rebuild Our Broken Antibiotic Pipeline”

Read More +
August 1, 2023
In the News

Policy Briefing: Recommendations for Creating a Sustainable Innovation Ecosystem for Antimicrobial R&D

Read More +
July 14, 2023
In the News

BioSpectrum: “Tech-Powered War on AMR”

Read More +
May 9, 2023
In the News

Duke-Margolis Center for Health Policy Webinar: “Drug-Resistant Infections & the Immediate and Future Demand for Novel Antimicrobials”

Read More +
April 13, 2023
In the News

GSK: “’It’s Insidious and It’s Getting Worse:’ AMR and the Urgent Need for Novel Antimicrobials”

Read More +
February 19, 2023
In the News

Financial Times: “Impact Funds Help Fight Dementia and Antibiotic Resistance”

Read More +
January 21, 2022
In the News

A timely reality check on silent pandemic of antimicrobial resistance

Read More +
November 18, 2021
In the News

Pressure grows for market reforms to help tackle ‘silent pandemic’ of AMR

Read More +
Previous page Next page
contact-bg-img

Connect With Us

Contact
footer_logo

Enabling
Breakthroughs in
Antimicrobials

Stay connected

Stay up-to-date on our work to bring 2 to 4 new antibiotics to patients by the end of the decade. When we have news, we will let you know.

  • About
  • Team
  • Latest
  • Threat of AMR
  • Connect
  • Investments
  • Japan Disclaimer
  • Privacy Policy